Subcutaneous dihydroergotamine mesylate (DHE) in the treatment of menstrual migraine

Authors
Category Primary study
JournalHeadache Quarterly
Year 1996
This article has no abstract
Epistemonikos ID: b17f90a83eb2866f82839dafa84bcb3b36bd6176
First added on: Feb 03, 2025